Related Experiment Video
Updated: Feb 19, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
4.1K
Advances in Immunotherapy for Breast Cancer
Oncology (Williston Park, N.Y.)
|February 17, 2026
Summary
Immunotherapy, including pembrolizumab, has transformed breast cancer treatment, especially for triple-negative breast cancer (TNBC). Ongoing research focuses on optimizing immunotherapy use for better survival and reduced toxicity in all breast cancer types.
Area of Science:
- Oncology
- Immunology
- Medical Treatments
Background:
- Immunotherapy has revolutionized cancer treatment, with significant impact on breast cancer care.
- Early research focused on advanced triple-negative breast cancer (TNBC) due to unmet clinical needs.
- The anti-PD-1 agent pembrolizumab combined with chemotherapy is now approved for advanced and early TNBC.
Purpose of the Study:
- To review pivotal clinical trials that have shaped current immunotherapy practices in breast cancer.
- To discuss ongoing trials investigating optimal patient selection, immunotherapy dosage, and combination therapies.
- To explore the evolving role of novel immunologic agents in breast cancer treatment.
Main Methods:
- Review of randomized phase 3 trials in early-stage, high-risk, hormone receptor-positive breast cancer.
- Analysis of data from trials evaluating immunotherapy in various breast cancer subtypes.
- Synthesis of findings from pivotal and ongoing clinical studies.
Main Results:
- Pembrolizumab plus chemotherapy shows promising efficacy in advanced and early TNBC.
- Phase 3 trials in high-risk, early-stage, hormone receptor-positive breast cancer demonstrate encouraging results.
- Current research is identifying optimal treatment strategies to maximize survival and minimize toxicity.
Conclusions:
- Immunotherapy has become a cornerstone in breast cancer treatment, particularly for TNBC.
- Future research aims to refine immunotherapy application for improved patient outcomes across breast cancer types.
- Novel immunologic agents are expected to further advance the therapeutic landscape for breast cancer.
More Related Videos
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
4.0K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.9K
Related Concept Videos
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
01:30Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K